Summary
Cytomegalic inclusion disease (CID) is caused by a horizontally or vertically transmitted human herpes virus infection and may persist for life without obvious clinical symptoms. A serious course of horizontal primary and recurrent infections, however, is often observed in immunocompromised persons such as recipients of organ transplants and patients receiving fresh blood transfusions. Vertical infection may cause fetopathies. The human cytomegalovirus (HCMV) is thought to inherit an oncogenic potential as lately discussed for AIDS and M. Kaposi. Laboratory diagnosis of HCMV infection is performed by light microscopy (inclusion bodies), electron microscopy, virus isolation in cell culture, demonstration of viral DNA and antigen in clinical specimens, by histochemical methods (e.g. immunoperoxidase technique) and by DNA and peptide analysis for identification of different isolates and viral finger prints. Evaluation of cell-mediated immunity in HCMV infection is performed quantitatively (assessment of Thelper/Tsuppressor ratios) or qualitatively (specific lymphocyte stimulation by the antigen). In most cases laboratory diagnosis is achieved by serological methods, i.e. demonstration and quantitation of HCMV-specific antibodies. In this context, a number of liquid- and solid-phase immunoassays have been developed, of which immunofluorescence and ELISA are most commonly used, besides complement fixation and passive haemaglutination. These procedures on the one hand allow the use of different antigen preparations as early and late viral proteins, and on the other hand permit a specific determination of different Ig classes and subclasses. A variety of assays has been established especially for determination of virus-specific IgM antibodies, which are predominantly found in active infection. These, however, at least in part may show non-specific results caused by interference of rheumatoid factor or IgG competition. Such problems have now been dealt with and are avoided by IgG precipitation or IgM immunosorption (“μ-capture” technique). These recent methods allow an exact epidemiological identification of risk groups for CMV infection. Results from our laboratory revealed 13% HCMV-IgM positive patients among pregnant women, 16% IgM positive patients among renal transplant recipients, 4% igM positive cases in patients after cardiosurgery and 1.7% IgM positives among prostitutes. The prevalence of HCMV infection as indicated by specific IgG antibodies was 56%, 90%, 83%, and 90%, respectively. No IgM antibodies were found in haemophiliacs and healthy blood donours, which showed a prevalence of HCMV infection in 69% and 47% of tested serum samples.
Article PDF
Similar content being viewed by others
Abbreviations
- ACIFT:
-
anti-complement immunofluorescence test
- AIDS:
-
acquired immunodeficiency syndrome
- CFT:
-
complement-fixation test
- CID:
-
cytomegalic inclusion disease
- ΔA492 :
-
difference of absorption values (λ=492 nm) (virus — neg. control antigen)
- DNA:
-
desoxyribonucleic acid
- EBNA:
-
EBV-nuclear antigen
- EBV:
-
Epstein-Barr virus
- ELISA:
-
enzyme-linked immunosorbent assay
- EM:
-
electron microscopy
- EV:
-
enveloped virus
- HBc, HBe, HBs ag:
-
hepatitis B virus c/e/s antigen
- HBV:
-
hepatitis B virus
- HCMV:
-
Human cytomegalovirus
- HSV:
-
herpes simplex virus
- (I)EA:
-
(immediate) early antigen
- IFT:
-
immunofluorescence test
- IgA, IgG, IgM:
-
immunoglobulin A, G, M
- LA:
-
late antigen
- NC:
-
nucleocapsid
- n.d.:
-
not done
- neg.:
-
negative
- NT:
-
neutralization test
- PHA:
-
passive haemagglutination
- RIA:
-
radioimmunoassay
- STR:
-
significant titer rise
- VZV:
-
varicella-zoster virus
References
Adler SP (1983) Transfusion-associated cytomegalovirus infections. Rev Infect Dis 5:977–993
Albrecht T, Rapp F (1973) Malignant transformation of hamster embryo fibroblasts following exposure to ultraviolet-irradiated human cytomegalovirus. Virology 55:56–61
Betts RF (1982) Cytomegalovirus infection in transplant patients. Prog Med Virol 28:44–64
Chou S, Merigan THC (1983) Rapid detection and quantitation of human cytomegalovirus in urine through DNA hybridizaltion. N Engl J Med 308:921–925
Colvin RB, Cosimi AB, Burton RC, Delmonico FL, Jaffers G, Rubin RH, Tolkhoff-Rubin NE, Giogi JV, McCluskey RT, Russel PS (1983) Circulating T-cell subsets in 72 human renal allograft recipients: the OKT 4+/OKT 8+ cell ratio correlates with reversability of graft injury and glomerulopathy. Transplant Proc 15:1166–1169
Condie RM, O'Reilly R (1984) Prevention of cytomegalovirus infection in bone marrow transplant recipients by prophylaxis with an intravenous, hyperimmune cytomegalovirus globulin. In: Plotkin SA, Michelson S, Pagano JS, Rapp F (eds) CMV: Pathogenesis and prevention of human infection. Birth defects: Original article series. Alan R Liss Inc, New York, 20, 1:327–344
Committee of Experts on Blood Transfusion and Immunohaematology: 22nd Meeting, Lisbon (1983) Vox Sang 45:451–454
Doerr HW (1980) Virologische Technik für den Sektionssaal. Pathologe 1:220–229
Doerr HW (1980) Ein einfacher Immunfluoreszenztest zum Nachweis zytomegalo-spezifischer (CMV-) IgM-Antikörper. Lab Med 4:206–207
Doerr HW, Fleischer G, Wiesmann M (1984) Nachweis von (Sub-) klassen-spezifischen IgG- und IgM-Rötelnantikörpern mit dem Enzymimmunassay (EIA). Immun Infekt 12:21–28
Doerr HW, Fretschner R, Geisen HP (1980) Virusspezifischer IgM-Nachweis mi Routinemethoden. Zentralbl Bakteriol [Orig A] 246:158–166
Doerr HW, Haas R, Munk K (1978) Cytomegalie und Schwangerschaft. Med in unserer Zeit 6:185–193
Doerr HW, Künzler A, Schmitz H (1979) Cytomegalovirus strain differentiation by DNA restriction analysis. Oncology 36:245–247
Doerr HW, Lehmair H, Schmitz H, Kampa D, Luthardt Th (1977) Simple mathematical deductions in the seroepidemiology of viral infections. I. Herpesvirusgroup (herpes virus hominis, varizella-zoster-virus, cytomegalovirus, Epstein-Barr-virus). Zentralbl Bakteriol [Orig A] 238:149–164
Fleckenstein B, Müller I, Collins J (1982) Cloning of the complete human cytomegalovirus genome in cosmids. Gene 18:39–46
Gärtner L, Ørstavik I (1984) Antibodies to cytomegalovirus-induced pre-early nuclear antigen in the anticomplement-immunofluorescent test in comparison to IgG and IgM antibodies in the indirect and direct enzyme-linked immunosorbent assay in diagnosing cytomegalovirus infections. Arch Virol 80:305–312
Geisen HP, Frank R, Doerr HW, Enders G (1979) Simple method to detect virus-specific IgM antibodies in patients' serum samples after immunosorption of immunoglobulins G and A. Med Microbiol Immunol 167:77–82
Goldstein LC, McDougall J, Hackman R, Meyers JD, Thomas ED, Nowinski RC (1982) Monoclonal antibodies to cytomegalovirus: Rapid identification of clinical isolates and preliminary use in diagnosis of cytomegalovirus pneumonia. Infect Immun 38:273–281
Gupta P, Jeor St, Rapp F (1977) Comparioson of the polypeptides of several strains of human cytomegalovirus. J Gen Virol 34:447–454
Haas R, Doerr HW, Petersen EE, Schmitz H (1977) Über die Vergleichbarkeit virusserologischer Befunde. Ein Beitrag zur Frage des Standardprinzips in der Virusdiagnostik. Bundesgesundh Bl 20:289–294
Hanshaw JB (1971) Congenital cytomegalovirus infection: A fifteen year perspective. J Infect Dis 123:555–561
Hanshaw JB (1976) Cytomegalovirus In: Remington JS, Klein JO (eds) Infectious diseases of the fetus and newborn infant. WB Saunders, Philadelphia London Toronto, pp 107–155
Höhne-Reichel G, Doerr HW (1984) Die Komplementbindungsreaktion (KBR) in der Virusserologie: Vergleich mit modernen Immunoassays an ausgewählten Fallbeispielen. Ärztl Lab 30:133–140
Horodniceanu F, MIchelson S (1980) Assessment of human cytomegalovirus antibody detection techniques. Arch Virol 64:287–301
Huang ES, Alford ChA, Reynolds DW, Stagno S, Pass RF (1980) Molecular epidemiology of cytomegalovirus infections in women and their infants. N Engl J Med 303:958–962
Huang ES, Pagano JS (1974) Human cytomegalovirus. II. Lack of relatedness to DNA of herpes simplex I and II, Epstein-Barr virus, and non-human strains of cytomegalovirus. J Virol 13:642–645
Huschka U, Stengel HH, Schroeter R, Roelcke D, Doerr HW (1982) Rapid detection of treponema pallidum and cytomegalovirus-specific IgM antibodies with the passive haemagglutination. Zentralbl Bakteriol [Orig A] 253:120–130
Kilpatrick BA, Huang ES, Pagano JS (1976) Analysis of cytomegalovirus genomes with restriction endonucleases HinD III and Eco R-1. J Virol 18:1095–1105
Krech UH, Jung M, Jung E (1971) Cytomegalovirus infections in man. Karger, Basel
Leroux M, Schindler R, Braun R, Doerr HW, Geisen HP, Kirchner H (1985) A Whole-blood lymphoproliferation assay for measuring cellular immunity against herpes viruses. J Immunol Meth (in press)
Linde GA, Hammerström L, Persson MMA, Smith E, Sundquist VA, Wahren B (1983) Virus-specific antibody activity of different subclasses of immunoglobulin G and A in cytomegalovirus infections. Infect Immun 42:237–244
Luthard TH (1976) Cytomegalie. Bücherei des Pädiaters, Band 75, Enke-Verlag, Stuttgart
Meyer J (1984) Zytomegalie und Nierentransplantation. Inaugural-Dissertation der Med Gesamtfakultät der Universität Heidelberg
Meyers JD (1984) Prevention and treatment of cytomegalovirus infections with interferons and immune globulin. Infection 12:143–150
Myerson D, Hackman RC, Myers JD (1984) Diagnosis of cytomegaloviral pneumonia by in situ hybridization. J Infect Dis 150:272–277
Nelson JA, Fleckenstein B, Jahn G, Galloway DA, McDougall JK (1984) Structure of the transforming region of human cytomegalovirus AD 169. J Virol 49:109–115
Pass RF, Griffith PD, August AM (1983) Antibody response to cytomegalovirus after renal transplantation: Comparison of patients with primary and recurrent infections. J Infect Dis 147:40–46
Peller P, Goetz O (1978) Zerebralschäden und Zytomegalievirusinfektion. Dtsch Med Wochenschr 103:265–267
Phillips CF (1977) Congenital cytomegalovirus disease. Is prevention possible? Prog Med Virol 23:62–68
Reynolds DW, Stagno S, Alford ChA (1979) Laboratory diagnosis of cytomegalovirus infections. In: Lennette EH, Schmidt NJ (eds) Diagnostic procedures for viral rickettsial and chlamydial infections. Am Publ Hlth Ass, Washington DC
Reynolds DW, Stagno S, Hosty TS, Tiller M, Alford CA jr (1973) Maternal cytomegalovirus excretion and perinatal infection. N Engl J Med 289:1–5
Rowe WP, Hartley JW, Waterman S, Turner AC, Huebner RJ (1956) Cytopathogenic agent resembling human salivary gland virus recovered from tissue cultures of human adenoids. Proc Soc Exp Biol Med 92:418–424
Sacks SL, Freeman HJ (1984) Cytomegalovirus hepatitis: evidence for direct hepatic viral infection using monoclonal antibodies. Gastroenterology 86:346–352
Sarov I, Siqueiva-Linhaves M, Chardonnet Y, Levy E, Aymard M, Bosshard S, Nord E, Revillard JP (1981) Detection of specific IgA antibodies in serum of kidney transplant patients with recurrent cytomegalovirus infection. Intervirology 15:228–234
Schmitz H, Deimling U, Flehming B (1980) Detection of IgM antibodies to cytomegalovirus (CMV) using an enzyme-labelled antigen (ELA). J Gen Virol 50:59–68
Schmitz H, Doerr HW, Kampa D, Vogt A (1977) Solidphase enzyme immunoassay for immunoglobulin M antibodies to cytomegalovirus. J Clin Microbiol 5:629–634
Schmitz H, Doerr HW, Obrig M (1975) Envelope and nucleocapsid antigens of cytomegalovirus (CMV). Med Microbiol Immunol 161:155–162
Schmitz H, Haas R (1972) Determination of different cytomegalovirus immunoglobulins (IgA, IgG, IgM) by immunofluorescence. Arch Ges Virusforsch 37:332–339
Schmitz H, Kampa D, Doerr HW, Luthardt Th, Hillemanns HG, Würtele A (1977) IgM antibodies to cytomegalovirus during pregnancy. Arch Virol 53:177–184
Seifert G (1961) Die morphologische Diagnose der Zytomegalie. Muench Med Wochenschr 103:139–143
Smith MG (1956) Propagation in tissue cultures of a cytopathogenic virus from human salivary gland (SGV) disease. Proc Soc Exp Biol Med 92:424–430
Simmons RL, Matas AJ, Rattazzi LC, Balfour HH, Howard RJ, Najarian JS (1977) Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. Surgery 82:537–546
Spector DH, Spector SA (1984) The oncogenic potential of human cytomegalovirus. Prog Med Virol 29:45–76
Spector SA, Rua JA, Spector DH, McMillan R (1984) Detection of human cytomegalovirus in clinical specimens by DNA-DNA hybridization. J Infect Dis 150:121–126
Stagno S, Volanakis JE, Reynolds DW, Stroud R, Alford ChA (1977) Immune complexes in congenital and natal cytomegalovirus infections in man. J Clin Invest 60:838–845
Vogt M, Bettex JD, Lüthy R (1983) Erworbenes Immundefektsyndrom (AIDS) Dtsch Med Wochenschr 108:1927–1933
Waner JL, Weller T, Kevy SV (1973) Patterns of cytomegaloviral complement-fixing antibody activity, a longitudinal study of blood donors. J Infect Dis 127:538–543
Weller TH, Hanshaw JB, Scott DE (1957) Isolation of intranuclear incluslion producing agents from infants with illness resembling cytomegalic inclusion disease. Proc Soc Exp Biol Med 94:4–12
Yeager AS, Grumet FC, Hafleigh EB, Arvin AM, Bradley JS, Prober CG (1981) Prevention of Tx-acquired cytomegalovirus infections in newborn infants. J Pediatr 98:281–287
Yolken RH, Stopa P (1980) Comparison of seven enzyme immunoassay-systems for measurement of cytomegalovirus. J Clin Microbiol 6:543–551
Author information
Authors and Affiliations
Additional information
Dedicated to Prof. Dres. mult. Wilhelm Doerr on his 70th birthday
Rights and permissions
About this article
Cite this article
Doerr, H.W., Braun, R. & Munk, K. Human cytomegalovirus infection: Recent developments in diagnosis and epidemiology. Klin Wochenschr 63, 241–251 (1985). https://doi.org/10.1007/BF01731469
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01731469